UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.01B |
| 2 |
Microsoft
MSFT
|
+$615M |
| 3 |
Sempra
SRE
|
+$496M |
| 4 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$438M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$353M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$514M |
| 2 |
Mondelez International
MDLZ
|
+$421M |
| 3 |
Cencora
COR
|
+$225M |
| 4 |
Invesco
IVZ
|
+$212M |
| 5 |
MON
Monsanto Co
MON
|
+$205M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.74% |
| 2 | Financials | 7.28% |
| 3 | Healthcare | 6.05% |
| 4 | Consumer Discretionary | 5.36% |
| 5 | Energy | 4.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PMF
3776
DELISTED
PIMCO Municipal Income Fund
PMF
| $982K | ﹤0.01% |
74,559
+31,239
| +72% | +$403K |
|
3777
BlackRock MuniYield Pennsylvania Quality Fund
MPA
$144M
| $981K | ﹤0.01% |
72,989
+1,072
| +1% | +$14.6K |
|
3778
CALL
PepsiCo
PEP
$190B
| $980K | ﹤0.01% |
9,000
-247,100
| -96% | -$25.5M |
|
3779
Conduent
CNDT
$264M
| $977K | ﹤0.01% |
53,757
+1,926
| +4% | +$37.2K |
|
3780
Scholastic
SCHL
$792M
| $972K | ﹤0.01% |
21,928
+21,082
| +2,492% | +$903K |
|
|
CLGX
3781
DELISTED
Corelogic, Inc.
CLGX
| $972K | ﹤0.01% |
18,725
+3,585
| +24% | +$180K |
|
3782
Invesco S&P MidCap Momentum ETF
XMMO
$7.53B
| $971K | ﹤0.01% |
+19,822
| New | +$950K |
|
3783
PUT
Hershey
HSY
$36.6B
| $968K | ﹤0.01% |
+10,400
| New | +$970K |
|
|
NVMI
3784
Nova
NVMI
$12.5B
| $967K | ﹤0.01% |
35,500
+14,116
| +66% | +$399K |
|
3785
State Street SPDR S&P Global Dividend ETF
WDIV
$281M
| $967K | ﹤0.01% |
14,349
-1,185
| -8% | -$81.5K |
|
3786
Century Communities
CCS
$2.03B
| $966K | ﹤0.01% |
30,602
+5,406
| +21% | +$166K |
|
3787
HNI Corp
HNI
$3.59B
| $965K | ﹤0.01% |
25,952
+12,895
| +99% | +$471K |
|
3788
Lennar Class B
LEN.B
$20.8B
| $965K | ﹤0.01% |
23,791
+4,078
| +21% | +$169K |
|
|
IBDC
3789
DELISTED
iShares iBonds Mar 2020 Term Corporate ETF
IBDC
| $965K | ﹤0.01% |
37,288
-4,125
| -10% | -$107K |
|
3790
Protolabs
PRLB
$2.13B
| $962K | ﹤0.01% |
8,084
-296
| -4% | -$36.2K |
|
|
IMGN
3791
DELISTED
Immunogen Inc
IMGN
| $962K | ﹤0.01% |
98,856
-377,467
| -79% | -$3.98M |
|
3792
Avista
AVA
$3.24B
| $959K | ﹤0.01% |
18,210
-8,654
| -32% | -$452K |
|
3793
Provident Financial Services
PFS
$3.19B
| $959K | ﹤0.01% |
34,843
+23,901
| +218% | +$649K |
|
3794
CALL
Biogen
BIIB
$30.7B
| $958K | ﹤0.01% |
3,300
-11,700
| -78% | -$3.29M |
|
|
JPM.WS
3795
DELISTED
JPMorgan Chase
JPM.WS
| $958K | ﹤0.01% |
15,106
+1,272
| +9% | +$88.3K |
|
3796
Citizens
CIA
$192M
| $954K | ﹤0.01% |
122,490
+17,398
| +17% | +$134K |
|
|
IRBT
3797
DELISTED
iRobot
IRBT
| $952K | ﹤0.01% |
12,553
-79,778
| -86% | -$5.3M |
|
3798
ProShares Long Online/Short Stores ETF
CLIX
$7.57M
| $949K | ﹤0.01% |
19,321
+15,632
| +424% | +$740K |
|
3799
Hope Bancorp
HOPE
$1.79B
| $948K | ﹤0.01% |
53,170
+25,304
| +91% | +$457K |
|
3800
Global X Uranium ETF
URA
$6.22B
| $948K | ﹤0.01% |
73,657
-9,194
| -11% | -$124K |
|
Similar funds
UBS Group's Q2 2018 Portfolio in Review
As of Q2 2018, UBS Group held 8,738 positions worth $231B, down 0.3% from $232B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2018 filing shows 866 new, 3,703 increased, 3,052 reduced and 702 closed positions. Its largest new stake was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M. The largest sale was NXP Semiconductors, an estimated $514M.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 8.1% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2018 buy was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $1.01B increase.
- UBS Group's biggest Q2 2018 reduction was NXP Semiconductors, cutting an estimated $514M.
- UBS Group fully exited Monsanto Co in Q2 2018, selling an estimated $205M.
- UBS Group's ten largest holdings make up 13% of its $231B portfolio in Q2 2018.
- UBS Group opened 866 new positions and closed 702 in Q2 2018.
- UBS Group's portfolio value fell 0.3% quarter-over-quarter to $231B.
Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.